Table 2.
Gene | PD outcome | Tissue | Replication | Sign. with max. lik. | Sign. with MR-Egger | MR-Egger intercept test | Cochran’s Q test | I2 test | pQTL evidence | Coloc | Previously published MR or coloc support |
---|---|---|---|---|---|---|---|---|---|---|---|
GPNMB | Risk | Blood | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | MR9 |
Risk | Brain | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | MR24; coloc33 | ||
CTSB | Risk | Brain | ✓ | ✓ | x | ✓ | ✓ | ✓ | ✓ | ✓ | MR9 |
Age at onset | Brain | ✓ | x | ✓ | ✓ | ✓ | |||||
VKORC1 | Risk | Blood | ✓ | ✓ | x | ✓ | ✓ | ✓ | ✓ | ||
CD38 | Risk | Brain | ✓ | ✓ | x | ✓ | ✓ | ✓ | x | x | Coloc33 |
Age at onset | Brain | ✓ | x | ✓ | ✓ | ✓ | |||||
MAP3K12 | Risk | Blood | ✓ | ✓ | x | ✓ | ✓ | ✓ | x | ||
NDUFAF2 | Risk | Brain | ✓ | ✓ | x | ✓ | ✓ | ✓ | x | ||
BST1 | Risk | Blood | ✓ | ✓ | x | x | ✓ | ✓ | ✓ | ✓ | MR9 |
Age at onset | Blood | ✓ | x | ✓ | ✓ | ✓ | ✓ | ||||
HSD3B7 | Risk | Blood | ✓ | ✓ | ✓ | ✓ | x | ||||
Risk | Brain | ✓ | ✓ | MR24 | |||||||
LGALS3 | Risk | Brain | ✓ | ✓ | ✓ | ||||||
ACVR2A | Risk | Brain | ✓ | ✓ | |||||||
CHRNB1 | Risk | Brain | ✓ | ✓ | MR9 | ||||||
MAPT | Risk | Brain | ✓ | ✓ | |||||||
MMRN1 | Risk | Brain | ✓ | ✓ | |||||||
Age at onset | Brain | ||||||||||
PIGF | Risk | Brain | ✓ | ||||||||
WNT3 | Risk | Blood | ✓ | ✓ | x | ✓ | x | x | x | MR9 |
✓ pass, x fail, blank not possible to test, coloc colocalization, max. lik. maximum likelihood, MR Mendelian randomization, PD Parkinson’s disease, pQTL protein quantitative trait locus, sign significant.